| Name | Title | Contact Details |
|---|
Healthcare Management Partners, LLC is a hospital and healthcare services management firm. HMP is a firm led by a team of C-Level healthcare executives that quickly define and solve problems to produce exceptional results for healthcare organizations and their stakeholders. With its extensive experience, Financial Modeling and Data Analysis Tools and action-based business model, HMP provides senior executive led management, financial advisory and litigation support services to hospitals and other healthcare organizations and their creditors, investors and business partners. The complex and ever-changing nature of the healthcare markets can test even the strongest organizations. Healthcare Management Partners serves as advisor to hospitals and other healthcare providers facing strategic decisions directly impacting current or future financial performance. HMP also frequently serves banks, bond holders, private equity firms or committees of unsecured creditors and their legal and accounting advisors in conjunction with complex business transactions or restructurings involving healthcare providers. We provide creditor advisory and operational and financial due diligence. Unlike many of our competitors, every financial advisory services engagement is led on the ground by experienced C-Level healthcare executives.
Career Directions NW is a Portland, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
lww vision care group is a Ambler, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Centrad Healthcare Inc is a Naperville, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
PharmaBlock Sciences (Nanjing), Inc. is a leading innovative chemistry products and services provider throughout the pharmaceutical R&D process. Its core businesses include: a catalog of specially designed scaffolds and building blocks; custom synthesis; process development; manufacturing of key intermediates and RSMs; and FTE services. The company was listed on Shenzhen Exchange Stock in China on November 10, 2017. PharmaBlock has rapidly gained recognition for its outstanding capability in the design, synthesis, and supply of lab scale building blocks. Building on that success, the company acquired Shandong Diai Biotechnology Co., Ltd. as its pilot plant and manufacturing site in 2016, and is providing scale-up synthesis and manufacturing of key intermediates/RSMs. PharmaBlock is now committed to a more comprehensive and long-term service to valued customers.